PT - JOURNAL ARTICLE AU - Pedro S. Peixoto AU - Diego Marcondes AU - Cláudia Peixoto AU - Lucas Queiroz AU - Rafael Gouveia AU - Afonso Delgado AU - Sérgio M. Oliva TI - Potential dissemination of epidemics based on Brazilian mobile geolocation data. Part I: Population dynamics and future spreading of infection in the states of São Paulo and Rio de Janeiro during the pandemic of COVID-19 AID - 10.1101/2020.04.07.20056739 DP - 2020 Jan 01 TA - medRxiv PG - 2020.04.07.20056739 4099 - http://medrxiv.org/content/early/2020/04/11/2020.04.07.20056739.short 4100 - http://medrxiv.org/content/early/2020/04/11/2020.04.07.20056739.full AB - Mobile geolocation data is a valuable asset in the assessment of movement patterns of a population. Once a highly contagious disease takes place in a location the movement patterns aid in predicting the potential spatial spreading of the disease, hence mobile data becomes a crucial tool to epidemic models. In this work, based on millions of anonymized mobile visits data in Brazil, we investigate the most probable spreading patterns of the COVID-19 within states of Brazil. The study is intended to help public administrators in action plans and resources allocation, whilst studying how mobile geolocation data may be employed as a measure of population mobility during an epidemic. The first part of the study focus on the states of São Paulo and Rio de Janeiro during the period of March 2020, when the disease first started to spread in these states. Metapopulation models for the disease spread were simulated in order to evaluate the risk of infection of each city within the states, by ranking them according to the time the disease will take to infect each city. We observed that, although the high risk regions are those closer to the capital cities, where the outbreak has started, there are also cities in the countryside with great risk.Competing Interest StatementThe authors have declared no competing interest.Funding StatementFAPESP financial support and computer resources under grant 16/18445-7 are acknowledged. D. Marcondes has received financial support from CNPq during the development of this article. Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesGeolocation data is proprietary, but all methods are available through open-source development. Additional data information, figures, and tables may be requested via email.https://github.com/pedrospeixoto/mdyn